Zobrazeno 1 - 2
of 2
pro vyhledávání: '"S Mendiola Garcia"'
Autor:
N Rudi Sola, D Ferrandez Marti, S Mendiola Garcia, V Charques Trallero, C Seguí Solanes, A Retamero Delgado
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Anti-interleukin-17 (IL-17) drugs are a new option for treating patients with psoriasis which have demonstrated high efficacy in clinical trials. Aim and objectives To analyse the effectiveness of anti-IL-17 drugs for psoria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f71a7b0a9a6a6a3f285d440132fb39e
https://doi.org/10.1136/ejhpharm-2020-eahpconf.125
https://doi.org/10.1136/ejhpharm-2020-eahpconf.125
Autor:
S Mendiola Garcia, LR López Giménez, B San Jose Ruiz, A Belaustegui Foronda, A De Basagoiti Gorordo, G Ros Bernaola
Publikováno v:
European Journal of Hospital Pharmacy. 23:A148.1-A148
Background Patients with chemosensitive neuroendocrine tumours are often treated with a capecitabine protocol (750 mg/m2/12 h day 1 to day 14) and temozolomide (200 mg/m2/24 h day 10 to day 14). A patient treated with this protocol in our centre pres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78ab1dd0ae975dfd9d044ba9faf66652
https://doi.org/10.1136/ejhpharm-2016-000875.334
https://doi.org/10.1136/ejhpharm-2016-000875.334